Bioregulators

Cartalax

A synthetic peptide bioregulator studied for cartilage and connective-tissue signaling.

Research use only. This page summarizes laboratory literature on Cartalax. It is not medical advice or a claim about effects in humans. Intended for in-vitro / laboratory research use only.
Also Known As
Cartilage bioregulator peptide
Category
Bioregulators
Regulatory Status
Research Use Only
Structure
Short synthetic peptide
🔬

Overview

Cartalax is a synthetic short-chain peptide developed within the same Russian “peptide bioregulator” research tradition that produced Epitalon and Pinealon. Rather than targeting a hormonal axis, bioregulator peptides like Cartalax are studied for organ- or tissue-specific regulatory signaling — in this case, cartilage and connective tissue.

⚙️

Mechanism of Action

Peptide bioregulator theory proposes that short peptides can interact with gene-regulatory regions to influence protein synthesis in a tissue-specific manner. For Cartalax, research within this framework has focused on cartilage and joint-tissue cell signaling, though the precise molecular mechanism is less extensively characterized in independently reproduced literature than that of better-known peptides in this library.

📖

Cited Research

Peptide bioregulator theory

Khavinson research program, Russian gerontology literature

Cartalax is part of a broader family of tissue-specific short peptide bioregulators studied by this research group.

Cartilage/connective-tissue signaling

Preclinical research

Studied for organ-specific regulatory effects on cartilage-associated cell populations.

This is a summary, not an exhaustive review. Search the primary literature yourself: Cartalax on PubMed →

🛡️

Safety & Handling

Cartalax should be handled only by qualified personnel in a laboratory setting, stored and reconstituted per its Certificate of Analysis, and kept refrigerated once reconstituted. It is not evaluated or approved by the FDA for any human or veterinary use.

❓

Frequently Asked Questions

What is a “peptide bioregulator”?

It’s a research category of very short peptides studied for organ- or tissue-specific regulatory effects, based on a research program developed in Russian gerontology institutes over several decades.

Is Cartalax legal to purchase?

It’s legal to sell and purchase as a research chemical for laboratory use in the U.S. It is not approved by the FDA as a drug or supplement for human consumption.

Is this page medical advice?

No. This page summarizes published literature for research and educational context only. It does not recommend a dose, protocol, or use in humans or animals outside a laboratory setting.

Have a specific question about Cartalax?

Ask Signal IQ Rx — our research assistant trained on the Signal Library.

Ask Signal IQ Rx →

← Back to the Signal Library

More on Cartalax